| # | Drug | Count |
|---|---|---|
| 0 | ENOXAPARIN SODIUM | 2 |
| 1 | ALEMTUZUMAB | 1 |
| 2 | ALLOPURINOL | 1 |
| 3 | DARATUMUMAB | 1 |
| 4 | ECULIZUMAB | 1 |
| 5 | FOLIC ACID | 1 |
| 6 | GLOFITAMAB | 1 |
| 7 | LEVETIRACETAM | 1 |
| 8 | LEVETIRACETAM IN SODIUM CHLORIDE | 1 |
| 9 | LEVETIRACETAM INJECTION | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GLOFITAMAB | 1 | 0.0004 |
| 1 | ALEMTUZUMAB | 1 | 0.0001 |
| 2 | SELEXIPAG | 1 | 0.0000 |
| 3 | ENOXAPARIN SODIUM | 2 | 0.0000 |
| 4 | NIFEDIPINE | 1 | 0.0000 |
| 5 | ECULIZUMAB | 1 | 0.0000 |
| 6 | RUXOLITINIB | 1 | 0.0000 |
| 7 | LEVETIRACETAM ORAL | 1 | 0.0000 |
| 8 | LEVETIRACETAM INJECTION | 1 | 0.0000 |
| 9 | LEVETIRACETAM | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 2 | Prostacyclin Receptor Agonist [EPC] | 1 | 0.0000 |
| 3 | Complement Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Janus Kinase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Xanthine Oxidase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Vitamin D [EPC] | 1 | 0.0000 |
| 7 | Vitamin B12 [EPC] | 1 | 0.0000 |
| 8 | Dihydropyridine Calcium Channel Blocker [EPC] | 1 | 0.0000 |
| 9 | Vitamin C [EPC] | 1 | 0.0000 |